Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1876

Similar articles for PubMed (Select 18753357)

1.

Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.

Gimeno C, Solano C, Latorre JC, Hernández-Boluda JC, Clari MA, Remigia MJ, Furió S, Calabuig M, Tormo N, Navarro D.

J Clin Microbiol. 2008 Oct;46(10):3311-8. doi: 10.1128/JCM.00797-08. Epub 2008 Aug 27.

2.

Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, Corey L.

J Clin Microbiol. 2004 Mar;42(3):1142-8.

3.

Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.

Pajand O, Ziyaeyan M, Mousavi S, Fatolahzadeh B, Hojabri Z, Bahador A, Abdossamadi Z.

Exp Clin Transplant. 2008 Jun;6(2):149-54.

PMID:
18816243
5.

Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma.

Leruez-Ville M, Ouachée M, Delarue R, Sauget AS, Blanche S, Buzyn A, Rouzioux C.

J Clin Microbiol. 2003 May;41(5):2040-6.

6.
7.

Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.

Ksouri H, Eljed H, Greco A, Lakhal A, Torjman L, Abdelkefi A, Ben Othmen T, Ladeb S, Slim A, Zouari B, Abdeladhim A, Ben Hassen A.

Transpl Infect Dis. 2007 Mar;9(1):16-21.

PMID:
17313466
8.

Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.

Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S, Torsellini M, Gerna G.

J Med Virol. 2004 Jul;73(3):412-8.

PMID:
15170637
9.

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.

Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M.

Bone Marrow Transplant. 2002 Apr;29(7):599-606.

10.

Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.

Sanghavi SK, Abu-Elmagd K, Keightley MC, St George K, Lewandowski K, Boes SS, Bullotta A, Dare R, Lassak M, Husain S, Kwak EJ, Paterson DL, Rinaldo CR.

J Clin Virol. 2008 Aug;42(4):335-42. doi: 10.1016/j.jcv.2008.03.031. Epub 2008 May 21.

PMID:
18495527
12.

Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients.

Choi SM, Lee DG, Lim J, Park SH, Choi JH, Yoo JH, Lee JW, Kim Y, Han K, Min WS, Shin WS, Kim CC.

J Korean Med Sci. 2009 Aug;24(4):571-8. doi: 10.3346/jkms.2009.24.4.571. Epub 2009 Jul 29.

13.
14.
15.

Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.

Martín-Dávila P, Fortún J, Gutiérrez C, Martí-Belda P, Candelas A, Honrubia A, Barcena R, Martínez A, Puente A, de Vicente E, Moreno S.

J Clin Virol. 2005 Jun;33(2):138-44. Epub 2004 Dec 16.

PMID:
15911429
16.

Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays.

Gracia-Ahufinger I, Tormo N, Espigado I, Solano C, Urbano-Ispizua A, Clari MA, de la Cruz-Vicente F, Navarro D, Pérez-Romero P.

J Clin Virol. 2010 Jun;48(2):142-6. doi: 10.1016/j.jcv.2010.03.015. Epub 2010 Apr 14.

PMID:
20395168
17.
18.

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.

Tormo N, Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, López-Aldeguer N, Hernández-Boluda JC, Remigia MJ, Garcia-Noblejas A, Gimeno C, Navarro D.

Bone Marrow Transplant. 2010 Mar;45(3):543-9. doi: 10.1038/bmt.2009.172. Epub 2009 Jul 20.

PMID:
19617905
19.

Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.

Hebart H, Rudolph T, Loeffler J, Middeldorp J, Ljubicic T, Jahn G, Einsele H.

Bone Marrow Transplant. 2002 Aug;30(3):181-7.

20.

CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.

Schulenburg A, Watkins-Riedel T, Greinix HT, Rabitsch W, Loidolt H, Keil F, Mitterbauer M, Kalhs P.

Bone Marrow Transplant. 2001 Oct;28(8):765-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk